Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Haematologica|August 4, 2006
An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patientsJean Baptiste Micol, Stéphane de Botton, Romain Guieze, et al.
Bulletin Du Cancer|October 9, 2025
Therapy related myeloid neoplasm, same but different?Lina El Murr, Khalil Saleh, Florence Pasquier, et al.
BMC Bioinformatics|August 20, 2015
A convex formulation for joint RNA isoform detection and quantification from multiple RNA-seq samplesElsa Bernard, Laurent Jacob, Julien Mairal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2014
Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trialsJean Baptiste Micol, Emmanuel Raffoux, Nicolas Boissel, et al.
Blood|August 22, 2014
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiationRodolphe Besancenot, Damien Roos-Weil, Carole Tonetti, et al.
Molecular Informatics|September 27, 2017
Kernel Multitask Regression for ToxicogeneticsElsa Bernard, Yunlong Jiao, Erwan Scornet, et al.
American Journal of Hematology|June 27, 2015
Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalitiesAnne Wanquet, Thomas Prebet, Céline Berthon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2013
Clinical efficacy of second generation tyrosine kinase inhibitor and 5-azacytidine combination in chronic myelogenous leukaemia in myeloid blast crisisDavid Ghez, Jean-Baptiste Micol, Florence Pasquier, et al.
Blood Cancer Journal|June 13, 2024
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA studyPierre Hirsch, Jérôme Lambert, Maxime Bucci, et al.
European Journal of Haematology|September 21, 2024
Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023Matteo Guerra, Emily Alouani, Thomas Hueso, et al.
Pageof 11